Medpace Holdings, Inc. (MEDP) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $417.74 (-0.22%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 6, 2026 | Luke Sergott | Barclays | $500.00 | +19.7% |
| Feb 13, 2026 | David Windley | Jefferies | $560.00 | +34.1% |
| Dec 15, 2025 | Luke Sergott | Barclays | $525.00 | +25.7% |
| Oct 27, 2025 | Jailendra Singh | Truist Financial | $555.00 | +32.9% |
| Mar 24, 2025 | Michael Cherny | Leerink Partners | $330.00 | -21.0% |
| Oct 23, 2024 | Eric Coldwell | Robert W. Baird | $349.00 | -16.5% |
| Sep 25, 2024 | David Windley | Jefferies | $345.00 | -17.4% |
| Aug 1, 2024 | Jailendra Singh | Truist Financial | $415.00 | -0.7% |
| Jul 8, 2024 | Eric Coldwell | Robert W. Baird | $469.00 | +12.3% |
| Jun 13, 2024 | Eric Coldwell | Robert W. Baird | $456.00 | +9.2% |
| May 28, 2024 | Ann Hynes | Mizuho Securities | $435.00 | +4.1% |
| Apr 23, 2024 | David Windley | Jefferies | $450.00 | +7.7% |
| Feb 15, 2024 | John Sourbeer | UBS | $452.00 | +8.2% |
Top Analysts Covering MEDP
MEDP vs Sector & Market
| Metric | MEDP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.91 | 2.24 | 2.41 |
| Analyst Count | 11 | 8 | 18 |
| Target Upside | +19.4% | +1150.3% | +14.9% |
| P/E Ratio | 26.24 | 6.84 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2.76B | $2.78B | $2.80B | 9 |
| 2027-12-31 | $2.77B | $2.92B | $3.06B | 9 |
| 2028-03-31 | $779M | $787M | $794M | 2 |
| 2028-06-30 | $800M | $808M | $815M | 2 |
| 2028-09-30 | $832M | $840M | $848M | 2 |
| 2028-12-31 | $860M | $869M | $877M | 2 |
| 2029-03-31 | $858M | $867M | $875M | 5 |
| 2029-06-30 | $893M | $902M | $911M | 4 |
| 2029-09-30 | $923M | $932M | $941M | 4 |
| 2029-12-31 | $935M | $945M | $953M | 5 |
| 2030-12-31 | $3.55B | $3.73B | $3.86B | 4 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $16.88 | $17.03 | $17.18 | 9 |
| 2027-12-31 | $17.85 | $18.49 | $18.98 | 9 |
| 2028-03-31 | $5.31 | $5.38 | $5.45 | 3 |
| 2028-06-30 | $5.24 | $5.31 | $5.37 | 3 |
| 2028-09-30 | $5.48 | $5.55 | $5.62 | 3 |
| 2028-12-31 | $5.81 | $5.89 | $5.96 | 3 |
| 2029-03-31 | $5.41 | $5.48 | $5.54 | 4 |
| 2029-06-30 | $5.54 | $5.61 | $5.68 | 3 |
| 2029-09-30 | $5.80 | $5.88 | $5.95 | 3 |
| 2029-12-31 | $5.89 | $5.97 | $6.04 | 4 |
| 2030-12-31 | $22.94 | $24.47 | $25.62 | 3 |
Frequently Asked Questions
What is the analyst consensus for MEDP?
The consensus among 11 analysts covering Medpace Holdings, Inc. (MEDP) is Hold with an average price target of $534.17.
What is the highest price target for MEDP?
The highest price target for MEDP is $560.00, set by David Windley at Jefferies on 2026-02-13.
What is the lowest price target for MEDP?
The lowest price target for MEDP is $330.00, set by Michael Cherny at Leerink Partners on 2025-03-24.
How many analysts cover MEDP?
11 analysts have issued ratings for Medpace Holdings, Inc. in the past 12 months.
Is MEDP a buy or sell right now?
Based on 11 analyst ratings, MEDP has a consensus rating of Hold (2.91/5) with a +19.4% upside to the consensus target of $534.17.
What are the earnings estimates for MEDP?
Analysts estimate MEDP will report EPS of $17.03 for the period ending 2026-12-31, with revenue estimated at $2.78B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.